Literaturverzeichnis

1 . National Cholesterol Education Program. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults Circulation 1994 ; 89 (3 ): 1333-1445

2 . Aakhus S., Dahl K., Wideroe T. E. Hyperlipidemia in renal transplant patients J Intern Med 1996 ; 239 (5 ): 407-415

3 . Anitschkow N. Über die Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose Beiträge zur pathologischen Anatomie und allgemeinen Pathologie 1913 (56 ): 379-404

4 . Aro A., Soimakallio S., Voutilainen E. et al. Serum lipoprotein lipid and apoprotein levels as indicators of the severity of angiographically assessed coronary artery disease Atherosclerosis 1986 ; 62 : 219-225

5 . Assmann G., Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease Am Heart J 1988 ; 116 : 1713-1724

6 . Austin M. A., Hokanson J. E. Epidemiology of triglycerides, small dense Low-Density Lipoprotein and Lipoprotein (a) as risk factors for coronary heart disease Med Clin North Am 1994 ; 78 (1 ): 99-112

7 . Avogaro P., Cazzolato G., Bittolo Bon G., Quinci G. B. Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet 1979 ; 28 : 901-903

8 . Bartens W., Wanner C. Lipoprotein (a): new insights into an atherogenic lipoprotein Clin Investig 1994 ; 72 (8 ): 558-567

9 . Betteridge D. J., Kahn M. Review of new guidelines for management of dyslipidemia Baillieres Clin Endocrinol Metab 1995 ; 9 (4 ): 867-890

10 . Bittar A. E., Ratcliffe P. J., Richardson A. J. The prevalence of hyperlipidemia in renal transplant recipients Transplantation 1990 ; 59 (6 ): 987-992

11 . Black I. W., Wilcken D. E. Decreases in apolipoprotein (a) after renal transplantation. Implications for lipoprotein (a) metabolism, Clin Chem 1992 ; 38 (3) : 353-357

12 . Boer J. M. A., Ehnholm C., Menzel H.-J. et al. Interactions between lifestyle-related factors and the apo E-polymorphismus on plasma lipids and apolipoproteins – the EARS study Arterioscler Thromb Vasc Biol 1997 ; 17 : 1675-1681

13 . Bumgardner G. L., Wilson G. A., Tso P. L. et al. Impact of serum lipids on long-term graft and patient survival after renal transplantation Transplantation 1995 ; 60 (12 ):1418-1421

14 . Castelao A. M., Barbera M. J., Blanco A. et al. Lipid metabolic abnormalities after renal transplantation under Cyclosporine and Prednisone immunsuppression Transplant Proc 1992 ; 24 (1 ): 96-98

15 . Cattin L., Fisicaro M., Tonizzo M. et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults Arterioscler Thromb Vasc Biol 1997 ; 17 : 91-94

16 . Corboy J., Sutherland W. H., Walker R. J. et al. Cholesteryl ester transfer in patients with renal failure or renal transplants Kidney Int 1994 ; 46 (4 ): 1147-1153

17 . Dahlen G. H., Guyton J. R., Attar M. et al. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography Circulation 1986 ; 74 (4 ): 758-765

18 . De Lorenzo F., Mukherjee M., Kadziola Z. et al. Association of overall adiposity rather than body mass index with lipids and procoagulant factors Thromb Haemost 1998 ; 80 : 603-606

19 . Dimény E. Metabolic factors and outcome of organ transplantation Scand J Urol Nephrol 1994 ; Suppl. 159

20 . Dimény E., Fellström B., Larsson E. et al. The role of lipoprotein abnormalities in chronic vascular rejection after kidney transplantation Transplant Proc 1995 ; 27 (3) : 2036-2039

21 . Dimény E., Tufveson G., Lithell H. et al. The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation Eur J Clin Invest 1993 ; 23 (9 ): 572-579

22 . Dimény E., Wahlberg J., Lithell H., Fellström B. Hyperlipidemia in renal transplantation - risk factor for long-term graft outcome Eur J Clin Invest 1995 ; 25 (8 ): 574-583

23 . Divakar D., Bailey R. R., Frampton C. M. et al. Hyperlipidemia in stable renal transplant recipients Nephron 1991 ; 59 (3 ): 423-428

24 . Downey P., Maiz A., Vaccarezza A. et al. Renal transplantation and dislipidaemia: Characterization of a population and treatment with diet and low dose Lovastatin Transplant Proc 1995 ; 27 (2 ): 1803-1805

25 . Dreikorn K. Meilensteine in der Geschichte der Nierentransplantation Nieren- und Hochdruckkrankheiten 1986 ; 15 (7 ): 297-308

26 . Drueke T. B., Abdulmassih Z., Lacour B. et al. Atherosclerosis and lipid disorders after renal transplantation Kidney Int Suppl 1991 ; 31 : 24-28

27 . Durrington P. N., Hunt L., Ishola M. et al. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction Br Heart J 1986 ; 56 : 206-212

28 . Fellström B. The effects of lipids on graft outcome Transpl Proc 1999 ; 31 (Suppl. 7a ): 14S-15S

29 . Fulton B., Markham A. Focus on Mycophenolate Mofetil Drugs 1996 ; 51 (2 ): 278-298

30 . Ginsberg H. N. Lipoprotein metabolism and its relationship to atherosclerosis Med Clin North Am 1994 ; 78 (1 ): 1-20

31 . Goldberg I. J. Lipoprotein metabolism in normal and uremic patients Am J Kidney Dis 1993 ; 21 (1 ): 87-90

32 . Goldstein S., Duhamel G., Laudat M. H. et al. Plasma lipids, lipoproteins and apolipoproteins AI, AII and B in renal transplanted children: What risk for accelerated atherosclerosis? Nephron 1984 ; 38 : 87-92

33 . Groth C. G. Landmarks in clinical renal transplantation Surg Gynecol Obstet 1972 ; 134 (2 ): 327-328

34 . Grützmacher P., März W., Peschke B. et al. Lipoproteins and apolipoproteins during the progression of chronic renal disease Nephron 1988 ; 50 : 103-111

35 . Guijarro C., Massy Z. A., Kasiske B. L. Clinical correlation between renal allograft failure and hyperlipidemia Kidney Int 1995 ; 48 (Suppl. 52 ): S56-S59

36 . Havel R. J. Biology of cholesterol, lipoproteins and atherosclerosis Clin Exp Hypertens A 1989 ; 11 (5-6 ): 887-900

37 . Heidenreich S., August C., Lang D. Langzeitprobleme bei nierentransplantierten Patienten Med Klin 2000 ; 95 : 261-266

38 . Hillebrand G. F., Schlosser S., Schneeberger H. et al. No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure Transpl Proc 1999 ; 31 : 1391-1392

39 . Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 1990 ; 31 (3 ): 545-548

40 . Hohage H., Arlt M., Brückner D. et al. Effects of Cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients Clin Transplantation 1997 ; 11 : 225-230

41 . Holdaas H., Hartmann A., Stenstrom J. et al. Effect of Fluvastatin for safely lowering atherogenic lipids in renal transplant patients recieving Cyclosporine Am J Cardiol 1995 ; 76 : 102A-106A

42 . Hopkins P. N., Williams R. R. A survey of 246 suggested coronary risk factors Atherosclerosis 1981 ; 40 (1 ): 1-52

43 . Hörl W. H., Riegel W., Wanner C. et al. Endocrine and metabolic abnormalities following kidney transplantation Klin Wochenschr 1989 ; 67 : 907-918

44 . Hricik D. E. Posttransplant hyperlipidemia: the treatment dilemma Am J Kidney Dis 1994 ; 23 (5 ): 766-771

45 . Inkeles S., Eisenberg M. P. H., Eisenberg D. Hyperlipidemia and coronary atherosclerosis: a review Medicine Baltimore 1981 ; 60 (2 ): 110-123

46 . Irish A. B., Simons L. A., Savdie E. et al Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation Aust N Z J Med 1992 ; 22 (3 ): 243-248

47 . Isoniemi H., Tikkanen M., Häyry P. et al. Lipid profiles with triple drug immunsuppressive therapy and with double drug combinations after renal transplantation and stable graft function Transplant Proc 1991 ; 23 (1 Pt 2 ): 1029-1031

48 . Kardia S. L. R., Haviland M. B., Ferrell R. E., Sing C. F. The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype Arterioscler Thromb Vasc Biol 1999 ; 19 : 427-435

49 . Kirste G. Stand und Entwicklung der Nierentransplantation Zentralbl Chir 1993 ; 118 (3 ): 113-117

50 . Kostner G. M., Avogaro P., Cazzolato G. et al. Lipoprotein Lp(a) and the risk for myocardial infarction Atherosclerosis 1981 ; 38 : 51-61

51 . Krauss R., Winston M. Obesity – impact on cardiovascular disease Circulation 1998 ; 98 : 1472-1476

52 . Kronenberg F., Dieplinger H., König P., Utermann G. Lipoprotein metabolism in renal replacement therapie - a review Isr J Med Sci 1996 ; 32 (6 ): 371-389

53 . Lye W. C., Hughes K., Leong S. O. et al. Abnormal Lipoprotein(a) and lipid profiles in renal allograft recipients: Effects of treatment with Pravastatin Transplant Proc 1995 ; 27 (1 ): 977-978

54 . Maher V. M., Brown B. G., Marcovina S. M. et al. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of Lipoprotein (a) JAMA 1995 ; 274 (22 ): 1771-1774

55 . Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 ; 240 : 622-630

56 . Margolis S. Clinical-review: diagnosis and management of abnormal plasma lipids J Clin Endocrinol Metab 1990 ; 70 (4 ): 821- 825

57 . Markell M. S., Armenti V., Danovitch G., Sumrani N. Hyperlipidemia and glucose intolerance in the postrenal transplant patient J Am Soc Nephrol 1994 ; 4 (1 ): 37-47

58 . Markell M. S., Sumrani N., DiBenedetto A., Friedman E. A. Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients Am J Kidney Dis 1993 ; 22 (1 ): 233-239

59 . Merion R. M., Twork A. M., Rosenberg L. et al. Obesity and renal transplantation Surg Gynecol Obstet 1991 ; 172 (5 ): 367-376

60 . Moorhead J. F. Lipids and progressive kidney disease Kidney Int Suppl 1991 ; 31 : S35-S40

61 . Muntner P., Coresh J., Clinton Smith J. et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study Kidney Int 2000 ; 58 : 293-301

62 . Nelson J., Beauregard H., Gelinas M. et al. Rapid improvement of hyperlipidemia in kidney transplant patients with a multifactorial hypolipidemic diet Transplant Proc 1988 ; 20 (6 ): 1264-1270

63 . Noma A., Yokosuka T., Kitamura K. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease Atherosclerosis 1983 ; 49 : 1-7

64 . Olbricht C. J. Pathophysiologie und Therapie von Lipidstoffwechselstörungen bei Nierenerkrankungen Klin Wochenschr 1991 ; 69 (11 ): 455-462

65 . Pollock C. A., Mahony J. F., Ong C. S. et al. Hyperlipidemia in renal transplant recipients: Does it matter and can we treat it? Transplant Proc 1995 ; 27 (3 ): 2152-2153

66 . Ponticelli C., Barbi G. L., Cantaluppi A. Lipid disorders in renal transplant recipients Nephron 1978 ; 20 : 189-195

67 . Pschyrembel - Klinisches Wörterbuch , 257. Auflage Walter de Gruyter Berlin New York 1994

68 . Raine A. E. G., Margreiter R., Brunner F. P. et al. Report on management of renal failure in Europe Nephrol Dial Transplant 1992 ; Suppl. 2 : 7-35

69 . Riesen W. F., Mordasini R. Hyperlipidemia in renal failure: Phenotypes and pathogenetic mechanisms Contr Nephrol 1984 ; 41 : 312-320

70 . Scanu A. M. Physiopathology of plasma lipoprotein metabolism Kidney Int 1991 ; 39 (Suppl. 31 ): S3-S7

71 . Scanu A. M., Fiess G. M. Lipoprotein (a) - heterogenity and biological relevance J Clin Invest 1990 ; 85 : 1709-1715

72 . Schmitz G., Lackner K. J. Lipid-lowering therapy - implications for the prevention of atherosclerosis Basic Res Cardiol 1994 ; 89 (Suppl. 1 ): 185-198

73 . Schwandt P., Richter W. O. Handbuch der Fettstoffwechselstörungen Schattauer Verlag Stuttgart New York 1995

74 . Segarra A., Chacon P., Martin M. et al. Serum lipoprotein (a) levels in patients with chronic renal failure - evolution after renal transplantation and relationship with other parameters of lipoprotein metabolism: a prospective study Nephron 1995 ; 69 (1 ): 9-13

75 . Sirtl C., Jesch F. Anästhesiologisches Notizbuch , 3. Auflage Wiss. Verl.-Abtlg. Abbott GmbH Wiesbaden

76 . Steinmetz A., Utermann G. Lipoprotein (a) als Risikofaktor für Arteriosklerose Internist 1992 ; 33 : 24-30

77 . Surdacki A., Wieczorek-Surdacka E., Sulowicz W., Dubiel J. S. Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy Nephrol Dial Transplant 1995 ; 10 : 1218-1223

78 . Sutherland W. H., Corboy J., Walker R.J. et al. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant Nephrol Dial Transplant 1995 ; 10 (3 ): 358-365

79 . Telci A., Salmayenli N., Aydin A. E. et al. Serum lipids and apolipoprotein concentrations and plasma fibronectin concentrations in renal transplant patients Eur J Clin Chem Biochem 1992 ; 30 (12 ): 847-850

80 . The Lipid Research Clinics Program Epidemiology Committee Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study Circulation 1979 ; 60 (2 ): 427-439

81 . Traindl O., Reading S., Franz M. et al . Treatment of hyperlipidemic kidney graft recipients with Lovastatin: Effect on LDL-cholesterol and Lipoprotein (a) Nephron 1992 ; 62 : 394-398

82 . Tribble D. L. Lipoprotein oxidation in dyslipidemia: Insights into general mechanisms affecting lipoprotein oxidative behaviour Curr Opin Lipidol 1995 ; 6 (4 ): 196-208

83 . Utermann G. The mysteries of Lipoprotein (a) Science 1989 ; 246 : 904-910

84 .: Vathsala A., Weinberg R. B., Schoenberg L. et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients, Transplantation 1989 ; 48 (1 ). 37-43

85 . Walden C. C., Hegele R. A. Apolipoprotein E in Hyperlipidemia Ann Intern Med 1994 ; 120 (12 ): 1026-1036

86 . Wanner C., Bartens W., Galle J. Clinical utility of antilipidemic therapies in chronic renal allograft failure Kidney Int 1995 ; 48 (Suppl. 52 ): S60-S62

87 . Wanner C., Frommherz K., Hörl W. H. Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects Cardiology 1991 ; 78 (3 ): 202-217

88 . Webb A. T., Plant M., Reaveley D. A. et al. Lipid and lipoprotein (a) concentrations in renal transplant recipients Nephrol Dial Transplant 1992 ; 7 : 636-641

89 . Wheeler D. C., Morgan R., Thomas D. M. et al. Factors influencing plasma lipid profiles including Lipoprotein (a) concentrations in renal transplant recipients Transpl Int 1996 ; 9 : 221-226

90 . Wissing K. M., Abramowicz D., Broeders N. et al. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection Transplantation 2000 ; 70 (3 ): 464-472

91 . Wüthrich R. P. Nierentransplantation , 2. Auflage Springer Verlag 1995